Literature DB >> 23890913

Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation.

Diego Conde1, Nicolas Lalor, Leandro Rodriguez, Pablo Elissamburu, Trivi Marcelo.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Electrical cardioversion; Vernakalant

Mesh：

Substances：

Year:  2013        PMID： 23890913     DOI： 10.1016/j.ijcard.2013.06.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Vernakalant for the conversion of atrial fibrillation: the new kid on the block?

Authors:  Diego Conde; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-16       Impact factor: 1.468

2.  Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis.

Authors:  Tamer Akel; James Lafferty
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-11-04       Impact factor: 1.468

3.  Suitability, efficacy, and safety of vernakalant for new onset atrial fibrillation in critically ill patients.

Authors:  Alain Rudiger; Alexander Breitenstein; Mattia Arrigo; Sacha P Salzberg; Dominique Bettex
Journal:  Crit Care Res Pract       Date:  2014-05-12

4.  Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.

Authors:  Andreas Müssigbrodt; Silke John; Jedrzej Kosiuk; Sergio Richter; Gerhard Hindricks; Andreas Bollmann
Journal:  Europace       Date:  2015-06-07       Impact factor: 5.214
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.